Streptozotocin

Introduction: What is Streptozotocin?

Streptozotocin is a chemotherapy medication FDA approved for metastatic islet cell carcinoma of the pancreas (including insulinomas and other pancreatic neuroendocrine tumors). It is derived from the bacterium Streptomyces achromogenes and is classified as an alkylating agent. Streptozotocin works by damaging the DNA of cancer cells, which inhibits their ability to grow and divide. This targeted approach makes it a valuable option in the management of specific malignancies.

Uses of Streptozotocin

Streptozotocin is primarily approved for the treatment of:

• Metastatic pancreatic islet cell carcinoma (including neuroendocrine tumors).
• Functional insulinomas: A rare type of tumor that produces excess insulin, leading to hypoglycemia.
• Off-label use in select non-pancreatic neuroendocrine tumors (e.g., carcinoid tumors) in combination regimens like streptozotocin-doxorubicin-5-FU (STZ-DAF), per NCCN guidelines.

How Does It Work?

Streptozotocin works by methylating DNA (primarily at the O6 position of guanine), causing DNA strand breaks and inhibiting replication. This leads to futile repair cycles and cell death. In simpler terms, you can think of it as corrupting the instructions (DNA) that tell cancer cells how to grow and multiply.

Dosage and Administration

Streptozotocin is typically administered via injection. The standard dosage for adults varies based on the specific condition being treated, but it generally falls within the following ranges:

• For Pancreatic Neuroendocrine Tumors: The usual dose is 1,000 mg/m? (1 g/m?) administered intravenously on days 1 and 8 of a 28-day cycle, or up to 500 mg/m? daily for 5 days every 6 weeks as alternative.
• For Insulinomas: Often lower initial doses (e.g., 500 mg/m?) due to hypoglycemia risk, adjusted based on response and tolerance.

Pediatric use is not FDA-approved; investigational only, determined by a specialist.

Side Effects of Streptozotocin

Like all medications, Streptozotocin can cause side effects. Common side effects include:

• Nausea and vomiting
• Loss of appetite
• Fatigue
• Diarrhea
• Severe nausea/vomiting (prophylaxis with antiemetics essential)

Serious side effects may include:

• High risk of nephrotoxicity (dose-limiting; requires hydration and monitoring)
• Hepatotoxicity
• Bone marrow suppression (myelosuppression), leading to low blood cell counts
• Allergic reactions

Patients should report any severe or unusual symptoms to their healthcare provider immediately.

Drug Interactions

Streptozotocin can interact with several medications, which may alter its effectiveness or increase the risk of side effects. Major drug interactions include:

• Other Chemotherapy Agents: Combining with other chemotherapy drugs may increase toxicity.
• Antidiabetic Medications: It can cause potentially severe hypoglycemia (especially in insulinoma patients), interacting with insulin or oral hypoglycemics; requires careful monitoring.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): These may increase the risk of kidney damage when used with Streptozotocin.
• Phenobarbital: Induces metabolism, reducing efficacy.

Always inform your healthcare provider about all the medications and supplements you are taking.

Benefits of Streptozotocin

Streptozotocin offers several clinical advantages:

• Selective beta-cell toxicity in pancreas: Explains insulinoma efficacy but also diabetes risk, leading to better outcomes in responsive patients.
• Effectiveness: Many patients experience significant tumor reduction or stabilization, improving quality of life.
• Established Use: Streptozotocin has a long history of use in oncology, providing a well-documented safety and efficacy profile.

Contraindications of Streptozotocin

Certain individuals should avoid using Streptozotocin, including:

• Pregnant Women: It can harm the fetus and is contraindicated during pregnancy.
• Patients with Severe Kidney Disease: Due to the risk of further kidney damage.
• Individuals with Liver Disease: It may exacerbate liver function issues.
• Prior severe hypersensitivity
• Inadequate bone marrow reserve

Always consult a healthcare provider to determine if Streptozotocin is appropriate for you.

Precautions and Warnings

Before starting treatment with Streptozotocin, patients should undergo specific lab tests to assess kidney and liver function. Regular monitoring of blood counts is also essential due to the risk of bone marrow suppression. Patients should be aware of the signs of low blood sugar and report any symptoms to their healthcare provider. Mandatory pre-treatment hydration (e.g., 1-2 L normal saline) and mannitol for nephroprotection; monitor with weekly CBC, LFTs, SCr.

FAQs

• What is Streptozotocin used for? Streptozotocin is primarily used to treat pancreatic neuroendocrine tumors and insulinomas.
• How is Streptozotocin administered? It is given as an injection, typically in a healthcare setting.
• What are the common side effects? Common side effects include nausea, vomiting, and fatigue.
• Can I take other medications with Streptozotocin? Yes, but inform your doctor about all medications to avoid interactions.
• Is Streptozotocin safe during pregnancy? No, it is contraindicated in pregnancy due to potential harm to the fetus.
• How does Streptozotocin work? It damages the DNA of cancer cells, preventing them from growing and dividing.
• What should I do if I miss a dose? Contact your healthcare provider for guidance on missed doses.
• Can Streptozotocin cause low blood sugar? Yes, especially with insulinomas.
• How often will I need to be monitored? Weekly initially, then biweekly blood tests to monitor kidney function and blood counts.
• What should I do if I experience severe side effects? Contact your healthcare provider immediately if you experience severe or unusual symptoms.

Brand Names

Streptozotocin is marketed under:

• Zanosar (primary US brand)
• Generic streptozotocin

Conclusion

Streptozotocin is a vital medication in the treatment of specific types of cancer, particularly pancreatic neuroendocrine tumors. Its targeted action on cancer cells, combined with a well-established safety profile, makes it a valuable option for patients. However, it is essential to be aware of potential side effects, drug interactions, and contraindications. Always consult with a healthcare provider for personalized medical advice and treatment plans.